Paucity of Sjögren-like syndrome in a cohort of HIV-1-positive patients in the HAART era. Part II

37Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective. This study was performed in order to investigate the prevalence of Sjögren-like syndrome (SLS) in the highly active anti-retroviral therapy (HAART) era in a cohort of HIV-1-positive Greek patients. Methods. One hundred and thirty-one unselected patients were screened by the validated European Union (EU) criteria for Sjögren's syndrome. Of the 31 who gave a positive EU-validated questionnaire, 17 consented to undergo minor salivary gland biopsy and other tests. Results. Only two patients had a positive salivary gland biopsy and both belonged to the non-compliant HAART group, whereas none of the compliant HAART patients had histological findings. Conclusions. It is concluded that SLS, the prevalence of which in the pre-HAART era was 7.8%, has disappeared, possibly as a result of the protective action of HAART.

Cite

CITATION STYLE

APA

Panayiotakopoulos, G. D., Aroni, K., Kyriaki, D., Paikos, S., Vouyioukas, N., Vlachos, A., … Kordossis, T. (2003). Paucity of Sjögren-like syndrome in a cohort of HIV-1-positive patients in the HAART era. Part II. Rheumatology, 42(10), 1164–1167. https://doi.org/10.1093/rheumatology/keg316

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free